NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 206 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,010 | -88.0% | 18,731 | -84.1% | 0.00% | -100.0% |
| Q2 2023 | $2,988,197 | -35.5% | 117,553 | -8.2% | 0.00% | -33.3% |
| Q1 2023 | $4,629,911 | -43.3% | 128,075 | -37.9% | 0.00% | -40.0% |
| Q4 2022 | $8,162,748 | +7.1% | 206,130 | +26.0% | 0.01% | 0.0% |
| Q3 2022 | $7,622,000 | +41.8% | 163,547 | +33.3% | 0.01% | +66.7% |
| Q2 2022 | $5,375,000 | -79.9% | 122,645 | -66.8% | 0.00% | -75.0% |
| Q1 2022 | $26,693,000 | +606.7% | 369,028 | +692.0% | 0.01% | +500.0% |
| Q4 2021 | $3,777,000 | -30.9% | 46,593 | -0.8% | 0.00% | -33.3% |
| Q3 2021 | $5,467,000 | -60.1% | 46,980 | -43.2% | 0.00% | -57.1% |
| Q2 2021 | $13,709,000 | +47.3% | 82,688 | +24.0% | 0.01% | +40.0% |
| Q1 2021 | $9,305,000 | -11.4% | 66,700 | +9.9% | 0.01% | -16.7% |
| Q4 2020 | $10,502,000 | +40.7% | 60,678 | +13.2% | 0.01% | +20.0% |
| Q3 2020 | $7,466,000 | +27.0% | 53,596 | +9.0% | 0.01% | +25.0% |
| Q2 2020 | $5,877,000 | -19.7% | 49,187 | -32.8% | 0.00% | -42.9% |
| Q1 2020 | $7,318,000 | +71.0% | 73,195 | +100.9% | 0.01% | +133.3% |
| Q4 2019 | $4,280,000 | +295.6% | 36,429 | +189.0% | 0.00% | +200.0% |
| Q3 2019 | $1,082,000 | -88.9% | 12,606 | -91.6% | 0.00% | -83.3% |
| Q2 2019 | $9,772,000 | -64.2% | 150,759 | -65.5% | 0.01% | -62.5% |
| Q1 2019 | $27,325,000 | +128.5% | 437,162 | +42.1% | 0.02% | +100.0% |
| Q4 2018 | $11,961,000 | -58.4% | 307,606 | -39.1% | 0.01% | 0.0% |
| Q3 2018 | $28,764,000 | -30.0% | 504,686 | -1.9% | 0.01% | -33.3% |
| Q2 2018 | $41,070,000 | +137.1% | 514,365 | +157.3% | 0.01% | +50.0% |
| Q1 2018 | $17,321,000 | -67.1% | 199,887 | -73.8% | 0.01% | -76.5% |
| Q4 2017 | $52,681,000 | -48.5% | 763,082 | -32.2% | 0.03% | -51.4% |
| Q3 2017 | $102,336,000 | +156.8% | 1,126,088 | +110.3% | 0.07% | +150.0% |
| Q2 2017 | $39,852,000 | +2135.1% | 535,449 | +2711.1% | 0.03% | +2700.0% |
| Q1 2017 | $1,783,000 | -83.2% | 19,048 | -87.0% | 0.00% | -88.9% |
| Q4 2016 | $10,604,000 | -38.0% | 145,969 | -10.9% | 0.01% | -25.0% |
| Q3 2016 | $17,105,000 | +26.8% | 163,871 | -10.4% | 0.01% | +20.0% |
| Q2 2016 | $13,485,000 | +110.9% | 182,845 | +60.9% | 0.01% | +100.0% |
| Q1 2016 | $6,393,000 | -54.5% | 113,669 | -45.4% | 0.01% | -50.0% |
| Q4 2015 | $14,057,000 | +6468.7% | 208,242 | +4406.4% | 0.01% | – |
| Q3 2015 | $214,000 | -93.0% | 4,621 | -91.9% | 0.00% | -100.0% |
| Q2 2015 | $3,071,000 | – | 57,158 | +476216.7% | 0.00% | – |
| Q1 2015 | $0 | – | 12 | +200.0% | 0.00% | – |
| Q4 2014 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |